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Abstract 
Background: Human enterovirus 71 (EV71) causes severe hand, foot and mouse disease, accompanied by neurologi-
cal complications. During the interaction between EV71 and the host, the virus subverts host cell machinery for its 
own replication. However, the roles of microRNAs (miRNAs) in this process remain obscure.
Results: In this study, we found that the miRNA hsa-let-7c-5p was significantly upregulated in EV71-infected rhabdo-
myosarcoma cells. The overexpression of hsa-let-7c-5p promoted replication of the virus, and the hsa-let-7c-5p inhibi-
tor suppressed viral replication. Furthermore, hsa-let-7c-5p targeted mitogen-activated protein kinase kinase kinase 
kinase 4 (MAP4K4) and inhibited its expression. Interestingly, downregulation of MAP4K4 expression led to an increase 
in EV71 replication. In addition, MAP4K4 knockdown or transfection with the hsa-let-7c-5p mimic led to activation of 
the c-Jun NH2-terminal kinase (JNK) signaling pathway, whereas the hsa-let-7c-5p inhibitor inhibited activation of this 
pathway. Moreover, EV71 infection promoted JNK pathway activation to facilitate viral replication.
Conclusions: Our data suggested that hsa-let-7c-5p facilitated EV71 replication by inhibiting MAP4K4 expression, 
which might be related to subversion of the JNK pathway by the virus. These results may shed light on a novel mecha-
nism underlying the defense of EV71 against cellular responses. In addition, these findings may facilitate the develop-
ment of new antiviral strategies for use in future therapies.
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Background
Human enterovirus 71 (EV71), which belongs to the 
genus Enterovirus in the family Picornaviridae, is a 
type of single-stranded positive-sense RNA virus that 
is known to be a major cause of hand, foot and mouth 
disease (HFMD) in young children. This virus may cause 
serious neurological complications compared with other 
pathogens associated with HFMD [1]. Since EV71 was 
first isolated in 1969 [2], several serious infectious out-
breaks have occurred, placing heavy burdens on society 
[3–7]. However, no effective drug has been identified for 
clinical application. Therefore, EV71 infection remains a 
public health concern.
MicroRNAs (miRNAs), a class of highly conserved 
small noncoding-RNAs, are 18–25 nucleotides (nts) 
in length. They post-transcriptionally modulate gene 
expression via mRNA degradation, mRNA cleavage, and 
translational repression [8–10]. MiRNAs are involved in 
a number of biological processes, such as cell cycle pro-
gression, cell survival and apoptosis [11–14]. Increasing 
evidence indicates that miRNAs also play a role in the 
pathogenesis of viral infectious diseases. Both DNA and 
RNA viruses can act as boosters, destroyers and hijackers 
in the regulation of cellular miRNAs to facilitate progres-
sion of their life cycles [15, 16].
The lethal-7 (let-7) miRNA was first discovered in 
Caenorhabditis elegans (C. elegans), in which it acts as 
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a key developmental regulator [17]. The Homo sapiens 
(H. sapiens) let-7 (hsa-let-7) family contains 13 individ-
ual members encoded on different chromosomes. The 
expression of these miRNAs, except for that of hsa-let-
7c, is meticulously regulated by lin28 [18–20]. Hsa-let-
7c is downregulated in most cancers and plays crucial 
roles in carcinogenesis and cancer metastasis [21–23]. 
In addition, it has been reported to be upregulated in 
response to RNA virus infection and to affect viral rep-
lication [24–26]. The miRNA let-7c has been shown to 
inhibit influenza virus replication by degrading viral 
gene M1 (+) cRNA in human lung epithelial cells [24]. 
Further, let-7c has been reported to suppress viral rep-
lication through targeting of the transcription factor 
BACH1 in dengue virus-infected human hepatoma 
Huh-7 cells [25]. Moreover, this miRNA may enhance 
HIV-1 infection by downregulating the cellular restric-
tion factor p21 [26]. However, its roles in mediating 
virus-host interactions through the regulation of host 
pathways have not been previously investigated. In addi-
tion, the regulation of hsa-let-7c-5p in EV71 replication 
has not yet been reported.
In this study, we showed that the hsa-let-7c-5p-
mediated regulation of mitogen-activated protein 
kinase kinase kinase kinase 4 (MAP4K4) might play an 
important role in EV71 replication. Hsa-let-7c-5p may 
modulate viral subversion of the c-Jun NH2-terminal 
kinase (JNK) signaling pathway and promote EV71 
replication.
Results
Mature miRNA hsa‑let‑7c‑5p expression is upregulated 
during EV71 infection
According to current and our previous studies, rhabdo-
myosarcoma (RD) cells and the Henrietta Lacks strain 
of cancer (HeLa) cells can be used as in vitro models to 
investigate the interplay between EV71 and its host [16, 
27–29]. To determine whether hsa-let-7c-5p is involved 
in EV71 infection, we first examined the expression of 
mature hsa-let-7c-5p in uninfected and EV71-infected 
RD cells by stem-loop quantitative reverse transcription 
polymerase chain reaction (qRT-PCR). The effect of EV71 
infection on hsa-let-7c-5p expression was detected at 12, 
24 and 36 h post-infection (p.i.), and the results showed 
that hsa-let-7c-5p expression was significantly increased 
in EV71-infected RD cells compared with mock-infected 
cells at 24  h p.i. (1.9-fold change) and 36  h p.i. (2.7-fold 
change) (Fig.  1, p  <  0.001). Similar hsa-let-7c-5p expres-
sion was detected in EV71-infected HeLa cells (Additional 
file  1: Figure S1). These data demonstrated that EV71 
infection upregulated the expression of hsa-let-7c-5p.
The overexpression of hsa‑let‑7c‑5p promotes EV71 
replication
To investigate the role of hsa-let-7c-5p during EV71 
infection, we first assessed the transfection efficiency 
of an hsa-let-7c-5p miRNA mimic in RD cells. A nega-
tive control (NC) miRNA mimic was also used in these 
experiments. Markedly increased hsa-let-7c-5p expres-
sion (by nearly 1000-fold) was observed in the hsa-
let-7c-5p-overexpressing group compared with the NC 
group (Fig. 2a, p < 0.01). As shown in Additional file  1: 
Figure S2 and Fig.  2b, the hsa-let-7c-5p mimic at con-
centrations of 50 nM (p < 0.01), 70 nM (p < 0.001) and 
100  nM (p  <  0.001) increased the virus titer compared 
with the NC mimic, and the highest virus titer was 
detected following treatment with 100 nM of the hsa-let-
7c-5p mimic. Thus, 100  nM of the hsa-let-7c-5p mimic 
was used in the following experiments. A substantially 
increased virus titer was observed in the hsa-let-7c-5p 
mimic group compared with the mock transfection 
(Mock-T) group (Fig.  2b, p  <  0.001). Further, the levels 
of viral RNA and the structural protein VP1 were signifi-
cantly increased in the hsa-let-7c-5p mimic group com-
pared with the NC mimic and Mock-T groups (Fig.  2c, 
p  <  0.001; Fig.  2d, p  <  0.01 and p  <  0.05, respectively). 
No difference in the virus titer, viral RNA level or VP1 
protein level was observed between the NC mimic and 
Mock-T groups (Fig.  2b–d). Next, to exclude the possi-
bility that hsa-let-7c-5p affects host cells, cell viability 
was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) assay. No significant 
Fig. 1 Relative expression of mature hsa-let-7c-5p is regulated by 
EV71 infection. RD cells were infected with EV71 (MOI = 5) or not 
(mock infection) at the indicated time points. The expression of 
hsa-let-7c-5p was detected by stem-loop qRT-PCR and normalized to 
that of U6 snRNA. The data are presented as the mean ± SD from one 
representative experiment, and all results here and in all subsequent 
figures were replicated three times. Significant differences are indi-
cated as follows: ***p < 0.001
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difference in cell viability was observed between hsa-
let-7c-5p mimic- and NC mimic-transfected mock-
infected RD cells (Fig.  2e). However, the hsa-let-7c-5p 
mimic reduced the survival of EV71-infected RD cells 
in contrast with the NC mimic (Fig. 2e, p < 0.05). Taken 
together, these data demonstrated that an increased hsa-
let-7c-5p level might promote EV71 replication and facil-
itate the viral impairment of host cells.
Fig. 2 EV71 replication is regulated by the hsa-let-7c-5p mimic. a The efficiency of transfection of the hsa-let-7c-5p mimic (100 nM) into RD cells for 
48 h was determined by stem-loop qRT-PCR. b The EV71 titer is altered by the hsa-let-7c-5p mimic. RD cells were transfected with the NC (100 nM), 
hsa-let-7c-5p (100 nM) or neither (mock transfection, Mock-T) for 48 h, followed by EV71 infection (MOI = 5) for 24 h. Total virus was collected from 
infected cells and culture supernatants and used in plaque assays. The virus titers in the cultures are expressed as plaque-forming units (PFU) per 
milliliter. c The expression of viral RNA and (d) the viral structural protein VP1 was assessed by qRT-PCR and Western blotting, respectively, after 
transfection of cells with the hsa-let-7c-5p mimic, and GAPDH was used as an internal control. RD cells were transfected with the NC (100 nM), 
hsa-let-7c-5p (100 nM) or neither for 48 h, followed by EV71 infection (MOI = 5) for 24 h. In addition, RD cells were subjected to mock infection, as 
shown in (d), to assess specificity of the VP1 primary antibody. The lower panel in (d) shows that VP1 expression normalized to GAPDH is expressed 
as a fold change compared with the Mock-T group, as quantified using Image J software. e The effect of the hsa-let-7c-5p mimic on cell viability 
was assessed by MTT assay. RD cells were transfected with the NC (100 nM) or hsa-let-7c-5p mimic (100 nM) for 48 h, followed by EV71 infection 
(MOI = 5) or mock infection for 24 h. Cell viability is expressed as percentages of the NC-transfected and mock-infected cells, which were used as 
controls. *p < 0.05; **p < 0.01; ***p < 0.001; ns no significance
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The inhibition of hsa‑let‑7c‑5p expression represses EV71 
replication
To further confirm the effect of hsa-let-7c-5p on EV71 
replication, cells were treated with a miRNA inhibitor. 
This inhibitor, referred to as hsa-let-7c-5pi in the paper, 
is a synthetic oligonucleotide with a sequence that is 
exactly complementary to hsa-let-7c-5p. A negative con-
trol miRNA inhibitor (NCi) was also used, which is a 
miRNA oligonucleotide from C. elegans whose sequence 
shows almost no homology with the genomes of H. sapi-
ens, Rattus norvegicus and Mus musculus.
To evaluate the effect of hsa-let-7c-5pi on hsa-let-7c-5p 
expression, 150 nM inhibitor oligonucleotide was trans-
fected into RD cells. Stem-loop qRT-PCR revealed that 
hsa-let-7c-5p expression was significantly decreased in 
the hsa-let-7c-5pi group compared with the NCi group 
(Fig. 3a, p < 0.001). In addition, the plaque assay results 
showed that hsa-let-7c-5pi significantly reduced the 
EV71 titer of the hsa-let-7c-5pi group compared with the 
NCi and Mock-T groups (Fig. 3b, p < 0.001). Further, both 
the viral RNA and VP1 protein levels were significantly 
suppressed in the hsa-let–5pi group compared with the 
NCi and Mock-T groups, as shown in Fig. 3c (p < 0.001) 
and Fig. 3d (p < 0.01 and p < 0.05, respectively). Moreo-
ver, no significant differences in the virus titer, viral RNA 
level or VP1 protein level were detected between the NCi 
and Mock-T groups (Fig. 3b–d). MTT assays revealed no 
significant difference in cell viability between the mock-
infected RD cells transfected with hsa-let-7c-5pi and 
those transfected with NCi (Fig.  3e). However, viability 
of the EV71-infected RD cells was enhanced in the hsa-
let-7c-5pi group compared with the NCi group (Fig. 3e, 
p  <  0.01). These results showed that the hsa-let-7c-5p 
inhibitor suppressed EV71 replication and protected host 
cells from EV71-induced cell death.
Hsa‑let‑7c‑5p directly inhibits the expression of MAP4K4 
by binding to its 3′UTR
To characterize the molecular mechanism associated 
with hsa-let-7c-5p function, we used an online miRNA 
prediction program, TargetScan, and the Starbase data-
base to comprehensively analyze potential targets [30–
32]. The results showed that MAP4K4 was a potential 
candidate target of hsa-let-7c-5p.
To date, the standard strategy used to validate miRNA 
targets involves artificial sensor assay, in which the 
3′UTR of a gene of interest is coupled to a reporter plas-
mid. A schematic diagram of the binding site of hsa-let-
7c-5p to the 3′UTR of the MAP4K4 mRNA is presented 
in Fig. 4a, and mutations in the sequence are highlighted 
in red and italic font. The luciferase assay results showed 
that the reporter activity of psi-MAP4K4-3′UTR was sig-
nificantly decreased in the hsa-let-7c-5p mimic group 
compared with the NC group (Fig. 4b, p < 0.001), whereas 
that of psi-MAP4K4-3′UTRmut did not significantly dif-
fer between the two groups (Fig. 4b).
To investigate the post-transcriptional regulation of 
hsa-let-7c-5p, we detected the MAP4K4 mRNA and pro-
tein levels by qRT-PCR and Western blotting, respec-
tively. The hsa-let-7c-5p mimic at a concentration of 
100  nM significantly reduced MAP4K4 mRNA expres-
sion compared with the NC mimic (Fig.  4c, p  <  0.001). 
In addition, the MAP4K4 protein level was obviously 
decreased in the hsa-let-7c-5p mimic group compared 
with the NC group (Fig. 4d, p < 0.001). To further validate 
the miRNA-target interaction, cells were treated with an 
hsa-let-7c-5p inhibitor to assess the regulatory effects of 
this miRNA at both the mRNA and protein levels. The 
hsa-let-7c-5p inhibitor oligonucleotide at a concentration 
of 150  nM increased the MAP4K4 mRNA and protein 
levels compared with the NC inhibitor (Fig. 4e, p < 0.05; 
Fig. 4f, p < 0.01). These data demonstrated that MAP4K4 
was a target of hsa-let-7c-5p and that hsa-let-7c-5p 
post-transcriptionally regulated MAP4K4 expression by 
directly binding to its 3′UTR.
MAP4K4 knockdown facilitates EV71 replication 
and activates the JNK signaling pathway
To detect whether MAP4K4 is involved in EV71 infec-
tion, we performed qRT-PCR and Western blotting. The 
results showed that MAP4K4 expression was signifi-
cantly decreased at both the mRNA and protein levels in 
EV71-infected RD cells compared with mock-infected 
cells at 24 and 36 h p.i. (Fig. 5a, b; p < 0.001). To further 
determine whether MAP4K4 affects EV71 replication, 
an shRNA pool was used to silence MAP4K4 expression. 
MAP4K4 expression was effectively silenced at both the 
mRNA and protein levels by the LV-shMAP4K4 vec-
tor in RD cells (Additional file 1: Figure S3). In addition, 
MAP4K4 expression was more strongly repressed by the 
LV-shMAP4K4-3 vector than by the other two vectors 
(Additional file 1: Figure S3). Thus, the LV-shMAP4K4-3 
vector was used in the subsequent experiments. A sig-
nificantly increased EV71 titer was detected in the LV-
shMAP4K4-3-transfected group compared with the 
LV-shcontrol-transfected group (Fig.  5c, p  <  0.001). 
Moreover, EV71-infected RD cells transfected with 
the LV-shMAP4K4-3 vector exhibited significantly 
reduced MAP4K4 expression at both the mRNA and 
protein levels compared with those transfected with the 
LV-shcontrol vector (Fig. 5d, p < 0.001; Fig. 5e, p < 0.05). 
Further, the EV71 RNA and VP1 protein levels were sig-
nificantly enhanced in the LV-shMAP4K4-3-transfected 
RD cells compared with the LV-shcontrol-transfected 
cells (Fig.  5d, p  <  0.001; Fig.  5e, p  <  0.01). The MTT 
assay results showed no significant difference in cell 
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viability between normal RD cells transfected with the 
LV-shMAP4K4-3 vector and those transfected with the 
LV-shcontrol vector (Fig.  5f ). However, the viability of 
EV71-infected RD cells was significantly decreased in 
the LV-shMAP4K4-3-tranfected group compared with 
the LV-shcontrol-transfected group (Fig.  5f, p  <  0.05). 
Thus, we concluded that EV71 infection resulted in the 
downregulation of MAP4K4 expression and that knock-
down of MAP4K4 promoted EV71 replication.
To further investigate the regulatory mechanism of 
EV71 replication by MAP4K4, the expression of proteins 
involved in the two major signaling pathways down-
stream of MAP4K4 (the JNK and NF-κB pathways) was 
assessed by Western blotting. The results showed that 
Fig. 3 EV71 replication is modulated by the hsa-let-7c-5p inhibitor. a The effect of transfection of hsa-let-7c-5pi (150 nM) into RD cells for 48 h on 
hsa-let-7c-5p expression was assessed by stem-loop qRT-PCR. b The virus titer is regulated by hsa-let-7c-5pi. RD cells were transfected with NCi 
(150 nM), hsa-let-7c-5pi (150 nM) or neither for 48 h and then infected with EV71 (MOI = 5) for 24 h. Total virus was collected from infected cells and 
culture supernatants and used in plaque assays. The virus titers in the cultures are expressed as PFU per milliliter. c Effects of the hsa-let-7c-5p mimic 
on the expression of viral RNA and (d) the viral structural protein VP1 were analyzed by qRT-PCR and Western blotting, respectively, using GAPDH 
as an internal control. RD cells were transfected with NCi (150 nM), hsa-let-7c-5pi (150 nM) or neither for 48 h, followed by EV71 infection (MOI = 5) 
for 24 h. The RD cells were subjected to mock infection, as shown in (d), to assess the specificity of the VP1 primary antibody. The lower panel in 
(d) shows that VP1 expression normalized to GAPDH is expressed as a fold change compared with the Mock-T group, as quantified using Image 
J software. e The effect of hsa-let-7c-5pi on cell viability was assessed by MTT assay. RD cells were transfected with NCi (150 nM) or hsa-let-7c-5pi 
(150 nM) for 48 h, followed by infection with or without EV71 (MOI = 5) for 24 h. Cell viability is expressed as percentages of the NCi-transfected and 
mock-infected cells, which were used as controls. *p < 0.05; **p < 0.01; ***p < 0.001; ns no significance
Page 6 of 14Zhou et al. Cell Biosci  (2017) 7:7 
the ratio of the phosphorylated JNK1/2 (p-JNK1/2) pro-
tein level to the total JNK1/2 protein level was higher in 
the LV-shMAP4K4-3-transfected group than in the LV-
shcontrol-transfected group (Fig. 6a, p < 0.05). The hsa-
let-7c-5p mimic similarly increased the p-JNK1/2 protein 
level (Fig.  6b, p  <  0.01). In contrast, the p-JNK1/2 pro-
tein level was significantly reduced in the hsa-let-7c-5pi 
group compared with the NCi group (Fig. 6c, p < 0.01). 
However, the phosphorylated NF-κB p65 (p-NF-κB p65) 
protein level was not significantly differ between RD cells 
transfected with the LV-shMAP4K4-3 vector and those 
with the LV-shcontrol vector (Additional file  1: Figure 
S3). Similar results were observed in the hsa-let-7c-5p 
mimic and hsa-let-7c-5pi groups compared with their 
Fig. 4 Target of hsa-let-7c-5p in MAP4K4. a Predicted binding site of hsa-let-7c-5p to the 3′UTR of human MAP4K4, as determined using TargetS-
can. b MAP4K4 was validated as a target of hsa-let-7c-5p by dual luciferase reporter assay. RD cells were transfected with a wild-type or mutant 
3′UTR vector (50 ng) for 6 h, followed by transfection of the NC (100 nM) or hsa-let-7c-5p mimic (100 nM) for 48 h. Renilla luciferase activity in each 
sample was normalized to Firefly luciferase activity. c The effect of the hsa-let-7c-5p mimic on the MAP4K4 mRNA level. RD cells were transfected 
with NC (100 nM) or hsa-let-7c-5p (100 nM) for 48 h. RNA was extracted and analyzed by qRT-PCR. d Regulation of the MAP4K4 protein level by 
the transfection of RD cells with the hsa-let-7c-5p mimic (100 nM) for 48 h, as demonstrated by Western blotting. The right panel in (d) shows that 
MAP4K4 expression normalized to GAPDH is expressed as a fold change compared with the NC mimic group, as quantified using Image J software. 
e The MAP4K4 mRNA level is affected by hsa-let-7c-5pi. RD cells were separately transfected with NCi (150 nM) and hsa-let-7c-5pi (150 nM) for 48 h, 
and then RNA was analyzed by qRT-PCR. f Regulation of the MAP4K4 protein level by the transfection of RD cells with hsa-let-7c-5pi (150 nM) for 
48 h, as demonstrated by Western blotting. The right panel in (f) shows that MAP4K4 expression normalized to GAPDH is expressed as a fold change 
compared with the NCi group, as quantified using Image J software. *p < 0.05; **p < 0.01; ***p < 0.001; ns no significance
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corresponding control groups (Additional file  1: Figure 
S3). These data showed that MAP4K4 knockdown and 
the hsa-let-7c-5p mimic activated the JNK signaling path-
way but not the NF-κB pathway, whereas JNK pathway 
activation was suppressed by the hsa-let-7c-5p inhibitor.
Subversion of the JNK signaling pathway by EV71 
promotes viral replication
As demonstrated above, the JNK signaling pathway is 
modulated by MAP4K4 and hsa-let-7c-5p. To investigate 
whether this pathway is involved in EV71 replication in 
Fig. 5 The effect of MAP4K4 knockdown on EV71 replication. a qRT-PCR and, b Western blotting were performed to assess the expression of 
MAP4K4 in response to EV71 infection in RD cells. RD cells were infected with or without EV71 at 5 MOI at the indicated time points. The right panel 
in (b) shows that the MAP4K4 protein level normalized to GAPDH is expressed as a fold change compared with the mock infection (24 h) group, as 
quantified using Image J software. c The effect of MAP4K4 knockdown on the virus titer was determined at 24 h p.i. by plaque assays. RD cells were 
transfected with the LV-shcontrol or LV-shMAP4K4-3 vector for 48 h, followed by infection with EV71 (MOI = 5) for 24 h. Total virus was collected 
from infected cells and culture supernatants and used in plaque assays. The virus titers in the cultures are expressed as PFU per milliliter. d Viral RNA 
and MAP4K4 mRNA expression and (e) VP1 protein and MAP4K4 protein expression following MAP4K4 knockdown were determined by qRT-PCR 
and Western blotting, respectively. The LV-shcontrol or LV-shMAP4K4-3 vector was transfected into RD cells for 48 h, followed by EV71 infection 
(MOI = 5) for 24 h. The right panel in (e) shows that the VP1 and MAP4K4 expression levels normalized to GAPDH are expressed as fold changes 
compared with the LV-shcontrol-transfected group, as quantified using Image J software. f The effect of MAP4K4 silencing on cell viability was 
assessed by MTT assay. RD cells were transfected with the LV-shcontrol (140 ng) or LV-shMAP4K4-3 (140 ng) vector for 48 h and then infected with 
or without EV71 (MOI = 5) for 24 h. Cell viability is expressed as percentages of the LV-shcontrol-transfected and mock-infected cells, which were 
used as controls. *p < 0.05; **p < 0.01; ***p < 0.001; ns no significance
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RD cells, we first detected JNK signaling pathway activity 
during EV71 infection by Western blotting. Total JNK1/2 
expression remained unchanged in EV71-infected RD 
cells at 3, 6, 12, 24 and 36 h compared with that in mock-
infected cells (Fig.  7a). However, the phosphorylated 
JNK1/2 level was increased in the EV71-infected cells at 
3, 6, 12, 24 and 36  h compared with the mock-infected 
cells, with peak expression observed at 12 h (Fig. 7a, b). 
To determine whether JNK pathway activity is affected 
during the early stage of infection, cells were infected 
with UV-inactivated EV71. The results showed that UV-
inactivated EV71 infection had no effect on the p-JNK1/2 
or total JNK1/2 protein level at 1, 3, 6, 12 or 24  h p.i. 
compared with mock infection (Fig.  7c, d). These data 
suggested that EV71 replication, but not EV71 infection, 
activated the JNK pathway.
To further confirm the link between EV71 replication 
and the JNK pathway in RD cells, we utilized a specific 
inhibitor of JNK, SP600125. No obvious cytopathic effect 
(CPE) on RD cells was observed at 24 or 36 h p.i. in the 
SP600125-treated group compared with the dimethyl 
sulfoxide (DMSO)-treated group (Fig. 8a). Furthermore, 
the virus titer was significantly reduced in the SP600125-
treated group compared with the DMSO-treated group 
(Fig.  8b, p  <  0.001). Moreover, the EV71 RNA and VP1 
protein levels were decreased by the SP600125 treatment 
compared with the DMSO treatment (Fig.  8c, p  <  0.01; 
Fig.  8d). These data demonstrated that EV71-induced 
JNK pathway activation facilitated EV71 replication in 
RD cells.
Discussion
Here, we reported that EV71 infection resulted in upreg-
ulation of expression of the cellular miRNA hsa-let-7c-5p 
and that hsa-let-7c-5p overexpression promoted viral 
replication by targeting MAP4K4 to activate the JNK 
signaling pathway in RD cells. These results suggested 
that EV71 might utilize hsa-let-7c-5p to subvert signaling 
pathways for its own benefit.
It is important to elucidate the interactions between 
EV71 and host cellular miRNAs. Comprehensive miRNA 
profiling has been performed using a deep sequencing 
approach, and certain miRNAs have been proposed to 
participate in crucial interactions with EV71 [33, 34]. On 
the one hand, host miRNAs may target the viral genome 
directly to suppress viral replication. Wen et al. [35] have 
reported that miRNA-23b expression is downregulated 
by EV71 infection and that this miRNA inhibits viral rep-
lication via suppression of the structural protein VP1. In 
addition, Zheng et  al. [36] have reported that hsa-miR-
295-5p expression is upregulated by EV71 infection and 
that this miRNA suppresses viral replication by targeting 
the VP1 and VP3 coding regions. On the other hand, host 
miRNAs may regulate EV71 replication by targeting host 
factors and immune signaling pathways [37, 38]. Tang 
et al. [37] have reported that host miR-197 expression is 
downregulated by EV71 and that this miRNA represses 
viral replication by targeting the host RAN, member RAS 
oncogene family protein. In addition, Xu et al. [38] have 
reported that host miR-526a expression is upregulated by 
EV71 and that this miRNA attenuates viral replication by 
Fig. 6 Regulation of the JNK signaling pathway by MAP4K4 and hsa-let-7c-5p. a The LV-shMAP4K4-3 vector, b hsa-let-7c-5p mimic (100 nM), c 
hsa-let-7c-5pi (150 nM) or corresponding control was transfected into RD cells for 48 h. The total JNK1/2 and p-JNK1/2 protein levels were analyzed 
by Western blotting. The ratios of the p-JNK1/2 to total JNK1/2 signals are expressed as fold changes compared with the corresponding controls, as 
quantified using Image J software (lower panels). *p < 0.05; **p < 0.01
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suppressing CYLD expression. Previously, we have found 
that miR-27a expression is downregulated and that hsa-
let-7c-5p expression is upregulated in RD cells during 
EV71 infection. Further, we have reported that miR-27a 
overexpression suppresses viral replication through the 
regulation of EGFR-mediated pathways [16]. It is of inter-
est to investigate the role of hsa-let-7c-5p miRNA upreg-
ulation in EV71 infection. In this study, we showed that 
the upregulation of hsa-let-7c-5p expression by EV71 
promoted viral replication by activating the JNK signal-
ing pathway downstream of MAP4K4.
MAP4K4, a member of the  human  STE20/mitogen-
activated protein kinase kinase kinase family of serine/
threonine kinases, is involved in multiple cellular pro-
cesses, such as cell motility, cytoskeletal rearrangement, 
and cell proliferation, as well as a complex network of 
signaling pathways. MAP4K4 is mainly associated with 
different types of cancer and diabetes [39, 40]. Notably, 
the roles of MAP4K4 in these biological processes and 
diseases involve the JNK and NF-κB signaling pathways 
[41–43]. MAP4K4 deficiency has been reported to sta-
bilize TRAF2 and induce TRAF2/IL-6 upregulation, 
leading to insulin resistance [44]. In addition, MAP4K4 
depletion has been shown to prevent primary CD4+ T 
cell proliferation and activation in  vitro and to reduce 
the expression of IL-2 and IFN-γ [45]. Further, JNK phos-
phorylation has been demonstrated to be enhanced by 
MAP4K4 depletion in CD4+  T cells exposed to ozone-
oxidized black carbon [46]. However, little is known 
regarding the function of MAP4K4 in EV71-infected RD 
cells. In our study, MAP4K4 knockdown also enhanced 
JNK1/2 phosphorylation. Moreover, EV71 infection 
resulted in the downregulation of MAP4K4 expression, 
and the silencing of MAP4K4 led to increased viral rep-
lication. These results implied that MAP4K4 might func-
tion as a novel antiviral regulator of EV71 replication.
Mammalian JNKs are encoded by three distinct genes, 
namely jnk1, jnk2 and jnk3. JNK1 and JNK2 are widely 
expressed in most cell types, and JNK3 expression is 
localized to the brain and testes [47]. JNK activation is 
Fig. 7 Modulation of JNK pathway activity by EV71 infection. a The effect of EV71 infection on JNK activity was assessed by Western blotting. RD 
cells were infected with EV71 (MOI = 5) at the indicated time points, and the data were analyzed by comparison with the mock-infected group. The 
ratios of the p-JNK1/2 to total JNK1/2 signals are expressed as fold changes compared with the mock-infected group, as quantified using Image J 
software, as shown in (b). c The effect of UV inactivation of EV71 on JNK activity was assessed by Western blotting. RD cells were infected with UV-
inactivated EV71 at the indicated time points, and the data were analyzed by comparison with the mock-infected group. The ratios of the p-JNK1/2 
to total JNK1/2 signals are expressed as fold changes compared with the mock-infected group, as quantified using Image J software, as shown in 
(d). *p < 0.05; **p < 0.01
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mediated by inflammatory cytokines (such as TNF, IL-1 
and TGF-β), Toll-like receptors and ligation of antigen 
receptors. The JNK pathway has been implicated in mul-
tiple diseases, including infectious diseases [48]. The JNK 
pathway has been shown to be required for the viral rep-
lication of herpes simplex virus, hepatitis B virus, hepati-
tis C virus, rotavirus, HIV-1 and human cytomegalovirus 
[49–54]. In addition, EV71 infection has been reported to 
activate the JNK pathway in immature dendritic cells and 
to promote the production of inflammatory cytokines, 
such as IL-6, IL-10 and TNF-α, whereas inhibition of this 
pathway results in the suppression of viral replication 
and the reduced secretion of cytokines [55]. In our study, 
EV71 replication activated the JNK pathway in RD cells, 
and blocking of the JNK pathway led to the inhibition of 
viral replication.
Conclusions
Collectively, the results of the present study have dem-
onstrated that the hsa-let-7c-5p inhibitor and MAP4K4 
might act as anti-EV71 modulators. Hsa-let-7c-5p 
might promote EV71 replication by targeting MAP4K4 
Fig. 8 Impact of the JNK inhibitor SP600125 on EV71 replication. a Effect of SP600125 on the CPE of EV71-infected RD cells. RD cells were pre-
treated with or without SP600125 for 1 h and infected with EV71 (MOI = 5) for 12, 24 or 36 h. Cell morphology was examined by light microscopy 
(40×). The CPE is labeled with red arrows. The scale bar is 100 μm, as shown in the first image. b Regulation of the virus titer by SP600125 at 24 h 
p.i. was assessed by plaque assays. The virus titers in the cultures are expressed as PFU per milliliter. c Regulation of the expression of EV71 RNA by 
SP600125 at 24 h p.i. was examined by qRT-PCR. d The effects of SP600125 on the VP1, total JNK1/2 and p-JNK1/2 protein levels were assessed by 
Western blotting. RD cells were pretreated with or without SP600125 for 1 h prior to EV71 infection (MOI = 5) or mock infection for 24 h. **p < 0.01; 
***p < 0.001
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expression. Moreover, hsa-let-7c-5p facilitates EV71 
replication partly through the MAP4K4/JNK axis. EV71 
infection may induce the upregulation of hsa-let-7c-5p, 
along with the downregulation of MAP4K4 and activa-
tion of the JNK pathway. These findings may indicate that 
EV71 uses an escape mechanism involving hsa-let-7c-
5p-mediated regulation of the MAP4K4/JNK pathway to 
promote its own replication.
Methods
Cell culture, transfection and reagents
RD cells and African green monkey kidney (Vero) cells 
were both cultured in minimum essential medium 
(MEM; HyClone, South Logan, UT, USA) supplemented 
with 10% heat-inactivated fetal bovine serum (FBS; PAN, 
Adenbach, Freistaat Bayern, Germany) and 100,000 U/L 
penicillin plus 100,000  g/L streptomycin at 37  °C and 
5% CO2. HeLa cells were grown in Dulbecco’s minimum 
essential medium (DMEM; HyClone, South Logan, UT, 
USA) supplemented with 10% heat-inactivated FBS 
and antibiotics (100,000 U/L penicillin and 100,000  g/L 
streptomycin) at 37  °C and 5% CO2. All cell lines were 
purchased from the China Center for Type Culture Col-
lection (CCTCC, Wuhan, China).
RD cells were transfected with synthetic oligonucleo-
tides or DNA plasmids using TurboFect transfection 
reagent (Thermo Scientific, Waltham, MA, USA) accord-
ing to the manufacturer’s protocol. Synthetic oligonu-
cleotides representing the hsa-let-7c-5p mimic, negative 
control miRNA mimic, hsa-let-7c-5p inhibitor and nega-
tive control miRNA inhibitor were purchased from Ribo 
Biotech (Guangzhou, China), and they were dissolved in 
RNase-free H2O at 20 μM for storage (at −80 °C).
A JNK inhibitor, SP600125, was purchased from Sigma-
Aldrich (St. Louis, MO, USA) and dissolved in DMSO 
(Sigma, St. Louis, MO, USA) at 10 mM, and this mixture 
was added to fresh culture medium (supplemented with 
1% heat-inactivated FBS and antibiotics) at a final con-
centration of 20  μM for 1  h prior to viral infection and 
kept in the medium throughout the experiment.
EV71 infection
Cells were starved, infected with EV71 (BrCr strain, Gen-
Bank accession No. U22521) at a multiplicity of infec-
tion (MOI) of 5 and incubated for 1 h at 37  °C to allow 
for absorption of the virus. Then, the inoculum was 
removed, and incubation was continued in fresh culture 
medium supplemented with 1% heat-inactivated FBS 
and antibiotics at 37  °C and 5% CO2. Infected cells and 
culture supernatants were collected together at the time 
points post-infection indicated in the text and figure leg-
ends and clarified by centrifugation (2000g). Finally, virus 
titers were determined by plaque assays.
To generate UV-inactivated virus, 2-mL aliquots of the 
virus were dispersed in a 6-cm tissue culture dish and 
then exposed to UV under a compact UV lamp (UVP, 
Upland, CA) for 1  h on ice. The remaining titer of the 
inactivated virus was determined by plaque assay [56].
Plasmid construction
To generate a psi-MAP4K4-3′UTR recombinant plas-
mid, a 927-nt partial fragment of the MAP4K4 3′UTR 
(GenBank accession No. NM_145686) was subcloned 
into a psiCHECK™-2 vector (Promega, Madison, WI, 
USA) using XhoI and NotI restriction sites. psi-MAP4K4-
3′UTRmut was generated by overlapping PCR; this 
plasmid contained a mutated seed sequence, which was 
changed from CUACCUC to CAUCGAC. The restric-
tion enzymes used in this experiment were purchased 
from Takara Bio (Dalian, China), and the LV-shMAP4K4 
vector was obtained from Longqian Biotech (Shanghai, 
China). The primers used for plasmid construction are 
listed in Additional file 1: Table S1.
RNA extraction and qRT‑PCR
Total RNA was extracted from cell lines with TRIzol Rea-
gent (Invitrogen, Carlsbad, CA, USA), and 2 μg isolated 
RNA was then reverse transcribed using a RevertAid First 
Strand cDNA Synthesis Kit (Thermo Scientific, Waltham, 
MA, USA). qRT-PCR was performed with SYBR Green 
Real-Time PCR Master Mix (Toyobo, Osaka, Japan) 
according to the manufacturer’s instructions. The PCR 
conditions for measuring mRNA and EV71 RNA levels 
were as follows: 95 °C for 3 min, followed by 40 cycles at 
95 °C for 10 s, 60 °C for 15 s and 72 °C for 20 s. GAPDH 
was used as an internal control, and the PCR primers 
used have been previously described [57]. In addition, 
the PCR conditions for measuring hsa-let-7c-5p expres-
sion were as follows, with U6 snRNA used as an internal 
control: 95 °C for 20 s, followed by 40 cycles at 95 °C for 
10 s, 60 °C for 20 s and 70 °C for 10 s. The primers used 
for reverse transcription and qRT-PCR of U6 snRNA 
have been previously described [58]. The sequence of 
the primer used for the reverse transcription of hsa-let-
7c-5p was 5′-GTCGTATCCAGTGCAGGGTCCGAGGT 
ATTCGCACTGGATACGACAACCAT-3′. The qRT-PCR 
primers used are listed in Additional file 1: Table S2. The 
data were analyzed using the 2−△△ct method.
Plaque assay
Vero cell monolayers were prepared by the addition of 
0.5  mL cells to each well of 48-well plates at a concen-
tration of 1 ×  105 cells per mL in MEM supplemented 
with 10% heat-inactivated FBS and antibiotics (Corning, 
NY, USA). The cells were incubated for 1 d before EV71 
infection. Then, the medium was removed, and the cells 
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were infected with 200 μL of a serial 10-fold-diluted viral 
suspension (with three replicates for each dilution). Next, 
the cells were incubated at 5% CO2 and 37 °C for 1 h, and 
the viral solution was aspirated. Subsequently, 500 μL of 
MEM supplemented with 1% heat-inactivated FBS and 
antibiotics plus 1% carboxymethyl cellulose was added to 
the wells. Then, the plates were incubated at 37 °C and 5% 
CO2 for 3 d, and the cells were fixed with methanol for 
1  h at 4  °C and subsequently stained with crystal violet 
for 10 min. Plaques were counted manually.
MTT assay
RD cells were seeded in 96-well plates (Corning, NY, 
USA) at 1 × 104 cells per well. Then, the cells were trans-
fected with the hsa-let-7c-5p mimic, miRNA inhibitor, 
LV-shMAP4K4 plasmid or corresponding negative con-
trol according to the manufacturer’s instructions. After 
4  h of incubation, the medium was aspirated, and then 
fresh MEM supplemented with 1% heat-inactivated FBS 
and antibiotics was added. After 48 h of transfection, the 
cells were further infected with or without EV71 for 24 h, 
followed by incubation with 20 μL of 5 mg/mL MTT for 
4 h. A volume of 150 μL DMSO was used to solubilize the 
formazan converted by MTT, and the plates were shaken 
for 10 min. Abosorbance was detected using a microplate 
reader (BioTek, VT, USA) at an OD of 490 nm.
Luciferase assay
RD cells were grown in 24-well plates (Corning, NY, 
USA) to 70% confluency and then transfected with a syn-
thetic oligonucleotide or DNA plasmid, as indicated in 
the text and figure legends. At specific time points post-
transfection, the cells were harvested and assayed using 
a Dual-Luciferase Reporter Assay System (Promega, 
Madison, WI, USA) according to the manufacturer’s 
instructions.
Western blotting analysis
RD cells were lysed on ice with RIPA buffer (Biosharp, 
China) containing phenylmethanesulfonyl fluoride 
(PMSF; Biosharp, China), and then the cell lysates were 
centrifuged at 10,000g for 5 min at 4 °C, and the pellets 
were discarded. The protein samples were separated 
in 8–12% polyacrylamide gels and then transferred to 
polyvinylidene difluoride (PVDF) membranes (Milli-
pore, Hertfordshire, UK). The membranes were blocked 
with 5% non-fat milk powder or bovine serum albumin 
(BSA) in Tris-buffered saline containing 0.1% Tween 
20 (TBST) at room temperature for 2 h and then incu-
bated overnight at 4  °C with the following primary 
antibodies (except for a membrane incubated with a 
mouse polyclonal antibody to enterovirus 71 for 48 h): 
a mouse polyclonal antibody to enterovirus 71 (1  μg/
mL; ab 169442, Abcam, Cambridge, MA, USA), goat 
polyclonal antibody to human HGK (1 μg/mL; AF6027, 
R&D, Minneapolis, MN, USA), rabbit monoclonal anti-
body to phospho-SAPK/JNK (diluted 1:1000; Thr183/
Tyr185, #4688, CST, MA, USA), rabbit anti-SAPK/
JNK polyclonal antibody (diluted 1:1000; #9252, CST, 
MA, USA), rabbit polyclonal antibodies to NF-κB and 
phospho-NF-κB (diluted 1:1000; CST, MA, USA), and 
GAPDH mouse monoclonal antibody (diluted 1:5000; 
PMK043C, PMK, Wuhan, China). Blots were washed 
and incubated for 1–2 h at room temperature with goat 
anti-rabbit, rabbit anti-mouse and anti-goat horseradish 
peroxidase-labeled antibodies (diluted 1:25,000; PMK). 
Protein band signals were detected by enhanced chemi-
luminescence (ECL; Thermo scientific, Waltham, MA, 
USA). Band densities were measured by densitometry 
and quantified using Image J software (version 1.46r, 
Bethesda, MD, USA).
Statistical analysis
All experiments were performed in triplicate. The data 
are expressed as the mean  ±  standard derivation (SD) 
and were analyzed by analysis of variance (ANOVA) or 
Student’s t test. Significant differences were indicated by 
a p < 0.05.
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